iiinova — where your digital self keeps evolving

Greg Medlock @gregmedlock.bsky.social · 14/10/2026

SPRIND has a very interesting funding challenge open for engineering microbial consortia. Closes Nov 16. apply here: www.sprind.org/en/actions/c...

poster for the engineering microbial consortia challenge describing the Nov 16 deadline and 4.3M Euro limit

120

Greg Medlock @gregmedlock.bsky.social · 13/08/2026

Travel grants are now available through NSF for ICME 2026, and abstract submissions were just extended to August 31. Please considering submitting an abstract and applying for the travel grant! Apply here: app.smartsheet.com/b/form/7c83c...

121

Greg Medlock @gregmedlock.bsky.social · 12/06/2026

I'm excited to help organize #ICME2026 - join us to explore the latest advances in Microbiome Engineering! Our call for abstract is open and we are seeking sponsors. Please share, and reach out to me to learn more!

Flyer for ICME 2026, hosted in Durham NC Dec 1-3 2026

263

Greg Medlock @gregmedlock.bsky.social · 21/05/2026

Our Call for Abstracts for ICME 2026 is now open—please share and consider submitting your work!

101

Greg Medlock @gregmedlock.bsky.social · 05/05/2026

Kicking off day 1 of #ksbeyondantibiotics26 with one foot of snow forecasted

Snow over the mountains during a time of year that there should not be snow

131

Greg Medlock @gregmedlock.bsky.social · 04/04/2026

Vedanta Biosciences Announces the Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection Will Continue as Planned Following Protocol-Specified Interim Analysis

252

Greg Medlock @gregmedlock.bsky.social · 28/02/2026

This is your cue to try Claude if you’ve been holding out still…

020

Greg Medlock @gregmedlock.bsky.social · 17/02/2026

CARB-X is opening a new funding round soon—sign up for their newsletter (link in replies) to get the announcement. CARB-X is one of few organizations making meaningful progress ensuring access to new antimicrobial drugs and supporting preventatives/diagnostics.

110

Greg Medlock @gregmedlock.bsky.social · 02/10/2025

Knowing the time without a watch

000

Greg Medlock @gregmedlock.bsky.social · 02/10/2025

Things I love about London: BOLLARDS

350

Greg Medlock @gregmedlock.bsky.social · 10/07/2025

After many months of waiting, there is one fewer gas appliance in the world! This battery-powered range from Copper (copperhome.com) helped us switch without needing a large electrical supply upgrade to our condo building.

Battery-powered induction stove called “Charlie” made by a startup named “Copper”.

560

Greg Medlock @gregmedlock.bsky.social · 31/01/2025

The audacity of these reminders on the red line

Frida baby ads on the MBTA red line for products for sick kids

000

Greg Medlock @gregmedlock.bsky.social · 07/01/2025

18F/-7C not stopping us from biking to the doctor’s appointment today!

Cutest sick toddler ever, chilling in a bucket bike

120

Greg Medlock @gregmedlock.bsky.social · 05/01/2025

Can’t believe my New Year’s resolution to read more books is off to such a great start. It’s only 120 pages, but I got through this one in one sitting today. Feeling so educated.

030

Greg Medlock @gregmedlock.bsky.social · 24/06/2024

Very excited to be in Rome at #IHMC2024 representing Vedanta Bio. This morning I will share updates related to our VE303 program, for which we recently recruited our first patient in a phase 3 pivotal trial. Please say hi to me after to learn more about Vedanta!

Me in front of one of many grandiose basilica (plural bacili?)

000

Greg Medlock @gregmedlock.bsky.social · 21/05/2024

We have enrolled the first patient in the pivotal Phase 3 study of VE303 for the prevention of recurrent C. difficile Infection. To our knowledge, this is the 1st registrational study of a Live Biotherapeutic Product for rCDI Read more from our CEO, Bernat Olle: www.linkedin.com/posts/bernat...

100